In recent weeks, a pair of high-profile disappointments have been reported, including one just announced on a trial of the Eli Lily drug solanezumab.
From: https://www.webmd.com/alzheimers/news/20180125/another-alzheimers-drug-fails-scientists-stymied?src=RSS_PUBLIC
No comments:
Post a Comment